# Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017)

> **NCT01043926** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 16 (actual)

## Conditions studied

- Insomnia
- Hepatic Insufficiency

## Interventions

- **DRUG:** Suvorexant

## Key facts

- **NCT ID:** NCT01043926
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02-22
- **Primary completion:** 2010-04-14
- **Final completion:** 2010-04-14
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01043926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01043926, "Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01043926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*